Literature DB >> 10774628

Limited sampling strategy for mycophenolic acid area under the curve.

G Filler1, I Mai.   

Abstract

The immunosuppressive potential of mycophenolate mofetil (MMF), a prodrug for mycophenolic acid, is related to the area under the time-concentration curve (AUC). Full pharmacokinetic (PK) profiles are expensive and cumbersome, and therefore a limited sampling technique would be favorable. The authors retrospectively analyzed 114 full 10-point PK profiles from 61 pediatric patients receiving MMF. Stepwise multiple regression analysis was used to calculate limited sampling approaches. Correlation between AUC and predose trough concentration was r2 = 0.29 (p < 0.0001), and between AUC and postdose trough concentration was r2 = 0.48 (p < 0.0001). The best correlations were with the 2 hours (C2, r2 = 0.59, p < 0.0001), three hours (C3, r2 = 0.52, p < 0.0001), 1.5 hours (C1.5, r2 = 0.50, p < 0.0001), and six hours (C6 r2 = 0.43, p < 0.0001). No combination of any two sampling points resulted in significantly better correlation with AUC, but three-point estimates at C1, C2, and C6 resulted in excellent correlation between predicted AUC and AUC from the full profile when using the formula AUC = 10.75 + (0.98 x C1) + (2.38 x C2) + (4.86 x C6), Pearson r = 0.93, 95% confidence interval 0.89 to 0.95. Bland and Altman analysis revealed good agreement between predicted AUC and AUC from the full profile. The AUC of mycophenolic acid can be predicted by limited sampling including C1, C2, and C6.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10774628     DOI: 10.1097/00007691-200004000-00005

Source DB:  PubMed          Journal:  Ther Drug Monit        ISSN: 0163-4356            Impact factor:   3.681


  24 in total

Review 1.  Clinical pharmacokinetics and pharmacodynamics of mycophenolate in solid organ transplant recipients.

Authors:  Christine E Staatz; Susan E Tett
Journal:  Clin Pharmacokinet       Date:  2007       Impact factor: 6.447

2.  Pharmacokinetics of mycophenolic acid and determination of area under the curve by abbreviated sampling strategy in Chinese liver transplant recipients.

Authors:  Hao Chen; Chenghong Peng; Zhicheng Yu; Baiyong Shen; Xiaxing Deng; Weihua Qiu; Yue Fei; Chuan Shen; Guangwen Zhou; Weiping Yang; Hongwei Li
Journal:  Clin Pharmacokinet       Date:  2007       Impact factor: 6.447

3.  Pharmacokinetics of mycophenolic acid in children with clinically stable idiopathic nephrotic syndrome receiving cyclosporine.

Authors:  Satoshi Hibino; Takuhito Nagai; Satoshi Yamakawa; Hidekazu Ito; Kazuki Tanaka; Osamu Uemura
Journal:  Clin Exp Nephrol       Date:  2016-04-22       Impact factor: 2.801

Review 4.  Therapeutic drug monitoring in pediatric renal transplantation.

Authors:  Lutz T Weber
Journal:  Pediatr Nephrol       Date:  2014-04-25       Impact factor: 3.714

Review 5.  The compelling case for therapeutic drug monitoring of mycophenolate mofetil therapy.

Authors:  Guido Filler; Ana Catalina Alvarez-Elías; Christopher McIntyre; Mara Medeiros
Journal:  Pediatr Nephrol       Date:  2016-02-26       Impact factor: 3.714

Review 6.  Immunosuppressive therapy for paediatric transplant patients: pharmacokinetic considerations.

Authors:  María del Mar Fernández De Gatta; Dolores Santos-Buelga; Alfonso Domínguez-Gil; María José García
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

Review 7.  Therapeutic monitoring of mycophenolate mofetil in organ transplant recipients: is it necessary?

Authors:  Michel Mourad; Pierre Wallemacq; Josiane König; Evelyne Henry de Frahan; Djamila Chaib Eddour; Martine De Meyer; Jacques Malaise; Jean Paul Squifflet
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

8.  Investigation on pharmacokinetics of mycophenolic acid in Chinese adult renal transplant patients.

Authors:  Yu Zicheng; Zhou Peijun; Xu Da; Wang Xianghui; Chen Hongzhuan
Journal:  Br J Clin Pharmacol       Date:  2006-10       Impact factor: 4.335

9.  Population pharmacokinetics and Bayesian estimation of mycophenolic acid concentrations in stable renal transplant patients.

Authors:  Chantal Le Guellec; Hélène Bourgoin; Matthias Büchler; Yann Le Meur; Yvon Lebranchu; Pierre Marquet; Gilles Paintaud
Journal:  Clin Pharmacokinet       Date:  2004       Impact factor: 6.447

10.  Population pharmacokinetic analysis of mycophenolic acid in renal transplant recipients following oral administration of mycophenolate mofetil.

Authors:  B Shum; S B Duffull; P J Taylor; S E Tett
Journal:  Br J Clin Pharmacol       Date:  2003-08       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.